PROCEPT BioRobotics

Highly Engaged Employees

PROCEPT BioRobotics Corporation, trading as NASDAQ: PRCT, is a commercial-stage surgical robotics company established in 2009 and headquartered in San Jose, California. The company is dedicated to developing transformative solutions within the field of urology, specifically targeting the treatment of benign prostatic hyperplasia (BPH), the most prevalent prostate disease. PROCEPT BioRobotics designs, manufactures, and markets advanced image-guided robotic systems engineered for minimally invasive urologic surgical procedures. Its innovative approach aims to provide patients with improved outcomes and a less invasive treatment pathway for common urological conditions.

The core of PROCEPT BioRobotics' offering is its proprietary robotic platform, which integrates real-time multidimensional imaging, personalized treatment planning, automated robotics, and a unique heat-free waterjet ablation technology. This system facilitates precise, targeted removal of prostate tissue, designed to deliver consistent and durable therapeutic results irrespective of prostate size, shape, or surgeon experience. Operating with an employee range of 500-1,000 employees, the company emphasizes its commitment to advancing surgical techniques. Meet PROCEPT BioRobotics's team to gain insight into the expertise driving these innovations.

With a reported revenue of $322.0M, PROCEPT BioRobotics demonstrates significant market presence in the medical device manufacturing sector. The company has a robust funding history, including substantial Series E, F, and G rounds, alongside debt financing, indicating strong investor confidence in its technology and market potential. This financial backing supports its ongoing research, development, and commercialization efforts. Explore financial highlights for a detailed overview of its fiscal performance and investment rounds.